Mount Sinai Names Dudley Leader of New Precision Health Enterprise | Healthcare Informatics Magazine | Health IT | Information Technology Skip to content Skip to navigation

Mount Sinai Names Dudley Leader of New Precision Health Enterprise

March 15, 2018
by David Raths
| Reprints
Strategic focus is on AI, consumer health, external partnerships

Mount Sinai Health System has created a Precision Health Enterprise to draw on the expertise of both its health system and the Icahn School of Medicine. To oversee this enterprise, the health system also created a new role: executive vice president for precision health.

Taking on the new role is Joel Dudley, Ph.D., director of the Institute for Next Generation Healthcare at the Icahn School of Medicine at Mount Sinai (ISMMS). In this new role, Dudley will be responsible for linking research conducted in the ISMMS with implementation strategies developed in collaboration with leadership and staff throughout the Health System.

Mount Sinai said the Precision Health Enterprise would focus on three key strategies:   

  • Intelligent Health Care – Artificial intelligence and predictive analysis will be applied to improve disease detection, treatment, and prevention. The school’s multidisciplinary Precision Medicine initiative will be central to data collection, generation, analysis, and application.
  • Consumer Health and Wellness – Moving beyond the hospital experience to manage the total health of our patients, the Enterprise will develop approaches to improve patient health and avoid hospitalization whenever possible.
  • External Partnerships – Recognizing the rapidly changing landscape of health care delivery and insurance, the Enterprise will forge new relationships with industry, particularly technology companies, to optimize quality of care and cost-effectiveness.

Dudley will work closely with Niyum Gandhi, the Health System’s Executive Vice President and Chief Population Health Officer, and Prabhjot Singh, M.D., Ph.D., Chair, Department of Health Systems Design and Global Health, and Director, The Arnhold Institute of Global Health at ISMMS.

“Mount Sinai is harnessing data from our large and diverse patient population to treat and heal patients, as well as develop a next-generation learning health system,” Dudley said in a prepared statement. “Our goal with the Precision Health Enterprise is to continue to personalize therapies for our patients, including those with conditions such as cancer, chronic diseases such as diabetes and Alzheimer’s disease, or rare genetic conditions. We believe that new product development, prototyping, artificial intelligence, predictive analysis, prevention, and partnerships will help us deliver better care in a rapidly changing health care ecosystem.”

Dudley will continue in his role as director of the Institute for Next Generation Healthcare at ISMMS. He is developing an integrated translational biomedical research model at the nexus of advances in omics, clinical medicine, digital health, and artificial intelligence. Under his leadership, the Institute has established a Next Generation Health Clinic in Manhattan to translate discoveries from computational data-driven approaches into personalized health care delivery to patients. Additionally, a Health Data and Design Innovation Center created in Silicon Valley expands the Institute’s ability to pursue innovations and develop programs that partner with emerging health technology startups. These initiatives dovetail with the goals of the Precision Health Enterprise.  

 

Get the latest information on Health IT and attend other valuable sessions at this two-day Summit providing healthcare leaders with educational content, insightful debate and dialogue on the future of healthcare and technology.

Learn More

Topics

News

Mass. General, Eastern Maine Healthcare Systems Form Clinical Affiliation

Massachusetts General Hospital will form a clinical affiliation with Eastern Maine Healthcare Systems, in which the two provider organizations will collaborate on areas as telemedicine, research, and protocols for providing care, according to a report in the Boston Globe.

Humanitarian Data Exchange Wins Health Data Liberator Award

Sarah Telford and Ahmadou Dicko were named the winners of this year’s Health Data Liberator award at the Health Datapalooza conference in Washington, D.C., for their work on the Humanitarian Data Exchange.

Survey: Optimism for Health IT Startups in 2018, Skepticism for Amazon Healthcare Partnership

Despite all the buzz about new entrants disrupting healthcare, the majority of healthcare stakeholders are dubious about the impact of the Amazon/Berkshire Hathaway/JP Morgan healthcare partnership and believe the effort will face substantial challenges, according to a survey by venture capital firm Venrock.

NIH Awards $10M to Alabama-based Newborn Genome Sequencing Project

The National Institutes of Health (NIH) has awarded a four-year, $10 million grant to HudsonAlpha Institute for Biotechnology, a Huntsville, Ala.-based genomics and genetics research institute, in collaboration with the University of Alabama at Birmingham (UAB) School of Medicine and the University of Mississippi Medical Center, to investigate how genome sequencing can help with the diagnosis and care of babies with birth defects and genetic disorders.

Senate Committee Advances Opioid Bill that Includes Telehealth Provisions

The Senate Health, Education, Labor and Pensions (HELP) Committee voted Tuesday to advance a bipartisan opioid bill, called the Opioid Crisis Response Act of 2018, that includes provisions promoting the use of telemedicine in substance abuse treatment.

Florida Insurer Establishes Digital Health and Wellbeing Program for Members

Florida Blue, a health insurer based in Jacksonville, has announced a partnership with Welltok. The goal of the collaboration will be to provide Florida Blue members with access to a digital health and wellbeing program designed to help them become and stay healthy.